Salih HR - Search Results

1

Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding.

Salih HR, Rammensee HG, Steinle A. Salih HR, et al. J Immunol. 2002 Oct 15;169(8):4098-102. doi: 10.4049/jimmunol.169.8.4098. J Immunol. 2002. PMID: 12370336

2

Soluble CD137 (4-1BB) ligand is released following leukocyte activation and is found in sera of patients with hematological malignancies.

Salih HR, Schmetzer HM, Burke C, Starling GC, Dunn R, Pelka-Fleischer R, Nuessler V, Kiener PA. Salih HR, et al. J Immunol. 2001 Oct 1;167(7):4059-66. doi: 10.4049/jimmunol.167.7.4059. J Immunol. 2001. PMID: 11564827

3

Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia.

Salih HR, Antropius H, Gieseke F, Lutz SZ, Kanz L, Rammensee HG, Steinle A. Salih HR, et al. Blood. 2003 Aug 15;102(4):1389-96. doi: 10.1182/blood-2003-01-0019. Epub 2003 Apr 24. Blood. 2003. PMID: 12714493 Free article.

4

Triggering receptor expressed on myeloid cells-1 in neutrophil inflammatory responses: differential regulation of activation and survival.

Radsak MP, Salih HR, Rammensee HG, Schild H. Radsak MP, et al. Among authors: salih hr. J Immunol. 2004 Apr 15;172(8):4956-63. doi: 10.4049/jimmunol.172.8.4956. J Immunol. 2004. PMID: 15067076

5

Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate.

Armeanu S, Bitzer M, Lauer UM, Venturelli S, Pathil A, Krusch M, Kaiser S, Jobst J, Smirnow I, Wagner A, Steinle A, Salih HR. Armeanu S, et al. Among authors: salih hr. Cancer Res. 2005 Jul 15;65(14):6321-9. doi: 10.1158/0008-5472.CAN-04-4252. Cancer Res. 2005. PMID: 16024634

6

Soluble MICA in malignant diseases.

Holdenrieder S, Stieber P, Peterfi A, Nagel D, Steinle A, Salih HR. Holdenrieder S, et al. Among authors: salih hr. Int J Cancer. 2006 Feb 1;118(3):684-7. doi: 10.1002/ijc.21382. Int J Cancer. 2006. PMID: 16094621

7

Soluble MICB in malignant diseases: analysis of diagnostic significance and correlation with soluble MICA.

Holdenrieder S, Stieber P, Peterfi A, Nagel D, Steinle A, Salih HR. Holdenrieder S, et al. Among authors: salih hr. Cancer Immunol Immunother. 2006 Dec;55(12):1584-9. doi: 10.1007/s00262-006-0167-1. Epub 2006 Apr 25. Cancer Immunol Immunother. 2006. PMID: 16636811 Free PMC article.

8

Release of MICB molecules by tumor cells: mechanism and soluble MICB in sera of cancer patients.

Salih HR, Goehlsdorf D, Steinle A. Salih HR, et al. Hum Immunol. 2006 Mar;67(3):188-95. doi: 10.1016/j.humimm.2006.02.008. Epub 2006 Mar 29. Hum Immunol. 2006. PMID: 16698441

9

Cancer immunoediting by GITR (glucocorticoid-induced TNF-related protein) ligand in humans: NK cell/tumor cell interactions.

Baltz KM, Krusch M, Bringmann A, Brossart P, Mayer F, Kloss M, Baessler T, Kumbier I, Peterfi A, Kupka S, Kroeber S, Menzel D, Radsak MP, Rammensee HG, Salih HR. Baltz KM, et al. Among authors: salih hr. FASEB J. 2007 Aug;21(10):2442-54. doi: 10.1096/fj.06-7724com. Epub 2007 Mar 14. FASEB J. 2007. PMID: 17360848

10

Soluble NKG2D ligands in hepatic autoimmune diseases and in benign diseases involved in marker metabolism.

Holdenrieder S, Eichhorn P, Beuers U, Samtleben W, Stieber P, Nagel D, Peterfi A, Steinle A, Salih HR. Holdenrieder S, et al. Among authors: salih hr. Anticancer Res. 2007 Jul-Aug;27(4A):2041-5. Anticancer Res. 2007. PMID: 17649819 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

225 results

Search Page

Filters